When acting on the melanocortin 1 receptor (MC1R), melanotan stimulates melanin production and tyrosinase activity, leading to melanocyte proliferation and skin hyperpigmentation (Figure 3)
Butyrate supplementation, for instance, enhances hepatocyte oxidative metabolism while suppressing lipogenic and pro-inflammatory gene expression, partly via HDAC inhibition and circadian gene activation
This trade-off between potency and tolerability is a central consideration in ongoing Phase 3 evaluation
But its role in skin health is particularly noteworthy
Walshs elevated SAH and SAH-hydrolase model
For Canadian researchers and consumers following the Retatrutide pipeline, these results are particularly significant because they strengthen the case for eventual Health Canada regulatory review, which will likely follow the FDA submission timeline